Clinical Trials Browser

Terminated × OTHER × ublituximab × Clear all

NCT04692155 2023-09-28

CHOP U2

Phase 1/2 Terminated

1 enrolled 5 charts

Lymphoma, Mantle-Cell

NCT04149821 2023-06-15

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Phase 2 Terminated

1 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Disease Progression